Tolerance Induced by Low Dose D-Penicillamine in the Brown Norway Rat Model of Drug-Induced Autoimmunity Is Immune-Mediated

Chemical Research in Toxicology

Volumn 17, Issue 1, 2004, Pages 82-94

  Masson, Mary Jane ^a   Uetrecht, Jack P ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 4; LIPOSOME; MESSENGER RNA; PENICILLAMINE; POLYINOSINIC POLYCYTIDYLIC ACID; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CYTOKINE PRODUCTION; DISEASE MODEL; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG TOLERANCE; IMMUNOLOGICAL TOLERANCE; LOW DRUG DOSE; MACROPHAGE; MEMORY CELL; NONHUMAN; RAT; RAT STRAIN; SPLEEN CELL; T LYMPHOCYTE;

ADMINISTRATION, ORAL; ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOIMMUNITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; DRUG TOLERANCE; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; MODELS, ANIMAL; PENICILLAMINE; POLY I-C; RATS; RATS, INBRED BN; RNA, MESSENGER; T-LYMPHOCYTES; TACROLIMUS; TIME FACTORS; WATER;

ANIMALIA; RATTUS NORVEGICUS;

EID: 1642457336     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx034195a     Document Type: Article

References (59)

1. Lasser, K. E., Allen, P. D., and Woolhandler, S. J., et al. (2002) Timing of new black box warnings and withdrawals for prescription medications J. Am. Med. Assoc. 287, 2215-2220.
2. Goldstein, R. A., and Patterson, R. (1984) Drug allergy: prevention, diagnosis, and treatment Ann. Intern. Med. 100, 302-303.
3. Bates, D. W., Cullen, D. J., and Laird, N., et al. (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group J. Am. Med. Assoc. 274, 29-34.
4. Uetrecht, J. P. (2000) Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions? Curr. Drug Metab. 1, 133-141.
5. Park, B. K., Pirmohamed, M., and Kitteringham, N. R. (1998) Role of drug disposition in drug hypersensitivity: A chemical, molecular, and clinical perspective. Chem. Res. Toxicol. 11, 969-988.
6. Balint, G., and Gergely, P., Jr. (1996) Clinical immunotoxicity of antirheumatic drugs. Inflammation Res. 45 (Suppl. 2), S91-S95.
7. Sim, E. (1989) Drug-induced immune-complex disease. Complement Inflammation 6, 119-126.
8. Emery, P., and Panayi, G. (1988) Penicillamine nephropathy. Br. Med. J. (Clin. Res. Ed.) 296, 1538.
9. Emery, P., and Panayi, G. S. (1989) Autoimmune reactions to D-penicilamine. In Autoimmunity and Toxicology (Kammuller, M., Bloksman, N., and Seinin, W., Eds.) pp 167-182, Elsevier, New York.
10. Donker, A. J., Venuto, R. C., and Vladutiu, A. O., et al. (1984) Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Brown Norway rats treated with D-penicillamine develop autoantibodies, circulating immune complexes, and disseminated intravascular coagulation. Clin. Immunol. Immunopathol. 30, 142-155.
11. Qasim, F. J., Thiru, S., and Gillespie, K. (1997) Gold and D-penicillamine induce vasculitis and up-regulate IL-4 in the Brown Norway rat: support for a Th2 cell activity. Clin. Exp. Immunol. 108, 438-445.
12. Mitchell, J. A., Gillam, E. M., and Stanley, L. A., et al. (1990) Immunotoxic side-effects of drug therapy. Drug Saf. 5, 168-178.
13. Tsang, I. K., P. D., Stein, H. B., Robinson, H. S., and Ford, K. D. (1977) D-penicillamine in the treatment of rheumatoid arthritis. Arthritis Rheum. 20, 667.
14. Nossal, G. J. (1987) How is tolerance generated? Ciba Found. Symp. 129, 59-72.
15. Webb, S., Morris, C., and Sprent, J. (1990) Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63, 1249-1256.
16. Mueller, D., and Jenkins, M. K. (1995) Molecular mechanisms underlying functional T-cell unresponsiveness. Curr. Opin. Immunol. 7, 375-381.
17. Schwarz, R. H. (1990) A cell culture model for T lymphocyte clonal anergy Science 248, 1349-1356.
18. Sakaguchi, S., Sakaguchi, N., and Asano, M., et al. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1156.
19. Groux, H., O'Garra, A., and Bigler, M., et al. (1997) A CD4+ T-cell subset inhibits antigen-specific-T-cell responses and prevents colitis Nature 389, 737-742.
20. Shevach, E. M. (2000) Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18, 423-449.
21. Fournie, G. J., Cautain, B., and Xystrakis, E., et al. (2001) Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases. Immunol. Rev. 184, 145-160.
22. Chen, Y., Kuchroo, V. K., and Inobe, J., et al. (1994) Regulatory T cell clones induced by oral tolerance: suppresssion of autoimmune encephalomyelitis. Science 265, 1237-1240.
23. Chen, W., Jin, W., and Wahl, S. M. (1998) Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells. J. Exp. Med. 188, 1849-1857.
24. Seddon, B., and Mason, D. (1999) Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8-(-) thymocytes. J. Exp. Med. 189, 279-288.
25. Seguin, B., Teranishi, M., and Uetrecht, J. P. (2003) Modulation of penicillamine-induced autoimmunity in the Brown Norway rat using pharmacological agents that interfere with arachidonic acid metabolism or synthesis of inducible nitric oxide synthase. Toxicology 190, 267-278.
26. Siegling, A., Lehmann, M., and Platzer, C., et al. (1994) A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J. Immunol. Methods 177, 23-28.
27. Van Rooijen, N., and Claassen, E. (1988) In vivo elimination of macrophages in spleen and liver, using liposome-encapsulated drugs: methods and applications. In Liposomes as Drug Carriers (Gregoriadis, G., Eds.) pp 131-143, Wiley, London.
28. van Rooijen, N., Bakker, J., and Sanders, A. (1997) Transient suppression of macrophage functions by liposome-encapsulated drugs. Trends Biotechnol. 15, 178-185.
29. Monshouwer, M., McLellan, R. A., and Delaporte, E., et al. (1996) Differential effect of pentoxifylline on lipopolysaccharide-induced downregulation of cytochrome P450. Biochem. Pharmacol. 52, 1195-1200.
30. DeClercq, E. (1981) Interferon induction by polynucleotides, modified polynucleotides and polycarboxylates. In Methods in Enzymology (Colowick, S. P., and Kaplan, N. O., Eds.) pp 227-235, Academic Press, New York.
31. Mosmann, T. R., and Sad, S. (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17, 138-146.
32. Bridoux, F., Badou, A., and Saoudi, A., et al. (1997) Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines. J. Exp. Med. 185, 1769-1775.
33. Kosiewicz, M. M., and Streilein, J. W. (1996) Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells. J. Immunol. 157, 1905-1912.
34. Field, A. C., Caccavelli, L., and Fillion, J., et al. (2000) Neonatal induction of tolerance to T(h)2-mediated autoimmunity in rats. Int. Immunol. 12, 1467-1477.
35. Tournade, H., Pelletier, L., and Pasquier, R., et al. (1990) D-penicillamine-induced autoimmunity in Brown-Norway rats. Similarities with HgCl2-induced autoimmunity. J. Immunol. 144, 2985-2991.
36. Szeto, C., Gillespie, K. M., and Mathieson, P. W. (1999) Low-dose mercuric chloride induces resistance in brown norway rats to further mercuric chloride by up-regulation of interferon-gamma. Scand. J. Immunol. 50, 195-201.
37. Field, A. C., Caccavelli, L., and Bloch, M. F., et al. (2003) Regulatory CD8+ T cells control neonatal tolerance to a Th2-mediated autoimmunity J. Immunol. 170, 2508-2515.
38. Pelletier, L., J. R., Pasquier, R., Vial, M. C., and Druet, P. (1990) Role of CD8+ T cells in mercury-induced autoimmunity or immunosupppression in the rat. Scand. J. Immunol. 31, 65-74.
39. Miller, A., Lider, O., and Roberts, A. B., et al. (1992) Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. U.S.A. 89, 421-425.
40. Seddon, B., and Mason, D. (1999) Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8-(-) thymocytes. J. Exp. Med. 189, 279-288.
41. Gorelik, L., and Flavell, R. A. (2000) Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171-181.
42. Kermarrec, N., Blanpied, C., and Pelletier, L., et al. (1995) Genetic study of gold-salt-induced immune disorders in the rat. Nephrol., Dial., Transplant. 10, 2187-2191.
43. Sayeh, E., and Uetrecht, J. P. (2001) Factors that modify penicillamine-induced autoimmunity in Brown Norway rats: failure of the Th1/Th2 paradigm. Toxicology 163, 195-211.
44. Gillespie, K. M., Saoudi, A., and Kuhn, J., et al. (1996) Th1/Th2 cytokine gene expression after mercuric chloride in susceptible and resistant rat strains. Eur. J. Immunol. 26, 2388-2392.
45. Fruman, D. A., Klee, C. B., and Bierer, B. E., et al. (1992) Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc. Natl. Acad. Sci. U.S.A. 89, 3686-3690.
46. Sullivan, J. R., and Shear, N. H. (2001) The drug hypersensitivity syndrome: what is the pathogenesis? Arch. Dermatol. 137, 357-364.
47. Ackerman, Z., and Levy, M. (1987) Hypersensitivity reactions to drugs in acquired immunodeficiency syndrome. Postgrad. Med. J. 63, 55-56.
48. Field, A. K., Tytell, A. A., and Lampson, G. P., et al. (1967) Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc. Natl. Acad. Sci. U.S.A. 58, 1004-1010.
49. Hill, H. F. (1979) Penicillamine in rheumatoid arthritis: adverse effects. Scand. J. Rheumatol. Suppl. 94-99.
50. Allison, A. C., and Byars, N. E. (1986) An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J. Immunol. Methods 95, 157-168.
51. Rocken, M., Urban, J. F., and Shevach, E. M. (1992) Infection breaks T-cell tolerance. Nature 359, 79-82.
52. Ehl, S., Hombach, J., and Aichele, P., et al. (1998) Viral and bacterial infections interfere with peripheral tolerance induction and activate CD81 T cells to cause immunopathology. J. Exp. Med. 187, 763-774.
53. Vella, A. T., McCormack, J. E., and Linsley, P. S., et al. (1995) Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2, 261-270.
54. Parks, D. E., Walker, S. M., and Weigle, W. O. (1981) Bacterial lipopolysaccharide (endotoxin) interferes with the induction of tolerance and primes thymus-derived lymphocytes. J. Immunol. 126, 938-942.
55. Ichikawa, H. T., Williams, L. P., and Segal, B. M. (2002) Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. J. Immunol. 169, 2781-2787.
56. Zhang, G. X., Xu, H., and Kishi, M., et al. (2002) The role of IL-12 in the induction of intravenous tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 168, 2501-2507.
57. Van Parijs, L., Perez, V. L., and Biuckians, A., et al. (1997) Role of interleukin 12 and costimulators in T cell anergy in vivo. J. Exp. Med. 186, 1119-1128.
58. Ju, C., and Uetrecht, J. P. (2002) Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system. Curr. Drug Metab. 3, 1-11.
59. Uetrecht, J. P. (1999) New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system. Chem. Res. Toxicol. 12, 387-395.